Sandoz Q3 Sales Miss Expectations on Europe Supply Constraints
Vontobel's Stefan Schneider says supply constraints for biosimilar drugs and a challenging German market hurt Sandoz Group's third-quarter sales.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.